Back
WAVE Life Sciences 10K Form
Sell
44
WVE
WAVE Life Sciences
Last Price:
14.25
Seasonality Move:
-6.6%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-09 | 10Q | WVE/WAVE Life Sciences Quarterly |
| 2023-08-03 | 10Q | WVE/WAVE Life Sciences Quarterly |
| 2023-05-03 | 10Q | WVE/WAVE Life Sciences Quarterly |
| 2022-11-10 | 10Q | WVE/WAVE Life Sciences Quarterly |
| 2022-08-11 | 10Q | WVE/WAVE Life Sciences Quarterly |
| 2022-05-12 | 10Q | WVE/WAVE Life Sciences Quarterly |
Receive WVE News And Ratings
See the #1 stock for the next 7 days that we like better than WVE
WVE Financial Statistics
Sales & Book Value
| Annual Sales: | $113.31M |
|---|---|
| Cash Flow: | $-46.86M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.95 |
| Price / Book: | 13.84 |
Profitability
| EPS (TTM): | -1.11000 |
|---|---|
| Net Income (TTM): | $-142.52M |
| Gross Margin: | $0 |
| Return on Equity: | -437.99% |
| Return on Assets: | -55.78% |
WAVE Life Sciences Earnings Forecast
Key WAVE Life Sciences Financial Ratios
- The Selling, General & Administrative Expenses for WVE have been equal to 45.27% of Gross Profit Margin.
- The Research & Development expenses have been 114.74% of Revenue.
- The Net Earning history of WVE is -50.76% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 4 years.
WAVE Life Sciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | WVE |
| CUSIP: | Y95308 |
| Website: | wavelifesciences.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.9 |
| Quick Ratio: | 1.82 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
WVE Technical Analysis vs Fundamental Analysis
Sell
44
WAVE Life Sciences (WVE)
is a Sell
Is WAVE Life Sciences a Buy or a Sell?
-
WAVE Life Sciences stock is rated a Sell
The current WAVE Life Sciences [WVE] share price is $14.26. The Score for WVE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.